Can You Smoke While on Mounjaro — and Does It Affect How the Treatment Works?

Why the licensing data does not cover smoking, and what that means for you

The SURMOUNT-1 trial, published in the New England Journal of Medicine and the foundation for NICE's recommendation of tirzepatide (TA1026), enrolled thousands of adults with obesity across 19 countries. Smoking status was recorded, but the trial was not designed to test a smoking–tirzepatide interaction specifically. That means there is no controlled evidence showing that smoking reduces tirzepatide's effectiveness in the way that, say, a drug interaction with oral contraceptives does. The tirzepatide overview explains the broader clinical profile of the medicine.

What the SURMOUNT programme did show, consistently, is that weight loss on tirzepatide was accompanied by meaningful improvements in blood pressure, blood lipids and blood sugar. Smoking erodes each of those markers independently. So even if the molecule itself is not blocked by nicotine, a person who continues to smoke is working against the cardiovascular and metabolic gains the treatment is trying to build.

The Mounjaro Summary of Product Characteristics (the official prescribing document on the Electronic Medicines Compendium) does not list smoking as a contraindication. It does require the prescriber to assess cardiovascular risk, which is precisely where smoking sits. Honest framing: the absence of a ban is not a green light. It is a gap in the evidence that puts more weight on the clinical conversation.

How nicotine and GLP-1 medicines overlap in your body

Tirzepatide works by activating two gut-hormone receptors, GIP and GLP-1, to reduce appetite, slow gastric emptying, and improve insulin signalling. Nicotine, through its own receptor pathways, also suppresses appetite, which is one reason people worry about weight gain when they quit smoking. This overlap is clinically relevant in two ways.

First, if you are still smoking while on Mounjaro, appetite suppression is coming from two sources at once. That is not inherently dangerous, but it does make it harder to assess how well the medicine is working on its own terms, and it raises the risk of under-eating to the point where protein and micronutrient intake suffer. Our guidance on what to take while on Mounjaro covers nutritional considerations worth reading alongside this.

Second, nicotine worsens insulin resistance over time. Since tirzepatide partly works by improving insulin sensitivity, smoking creates a persistent headwind. Studies have consistently linked current smoking to higher fasting insulin and impaired glucose tolerance in people with obesity, the same population that Mounjaro is licensed to treat. This is not a theoretical concern; it is the kind of real-world variable that a prescriber takes into account when reviewing your progress at each repeat consultation.

Inflammation matters here too. Chronic smoking raises systemic inflammatory markers, including CRP and IL-6. Excess visceral fat drives the same markers upward. Tirzepatide's weight-loss effect tends to reduce inflammatory burden as weight falls, but active smoking partially offsets that benefit. If you have also been wondering whether smoking on Mounjaro is something other patients ask about, our dedicated page looks at the question in full. None of this makes treatment pointless; it does make honest disclosure to your prescriber important.

Quitting smoking during Mounjaro treatment, timing and what your prescriber needs to know

A planned quit attempt while you are on Mounjaro is generally considered a positive step. However, stopping smoking often triggers a short-term increase in appetite and a modest rise in body weight, most likely because nicotine's appetite-suppressing effect is removed. This can overlap in confusing ways with how tirzepatide affects your weight trajectory.

If your prescriber does not know a quit attempt is underway, they may misread a temporary weight plateau or slight regain as treatment failure, when the picture is actually more complicated. Sharing that information means the clinical review stays accurate. You can also discuss this through our support team, who can pass it to the prescribing team quickly.

Nicotine replacement therapy (NRT) (patches, gums, lozenges) does not appear in the Mounjaro SmPC as a known interaction. That said, NRT is still pharmacologically active, and a prescriber should know you are using it. Varenicline (Champix, where available) and bupropion have their own interaction profiles; always disclose them.

For practical context: if you keep your Mounjaro pen in the fridge and follow a morning routine that already involves other health habits, adding a smoking-cessation aid to that routine is something your clinical team can help you plan. Small habit changes compound. Your prescriber is the right person to sequence them.

What to discuss with your prescriber before your next review

The NHS notes that weight-management medicines work best alongside lifestyle changes, and smoking is one of the larger lifestyle variables at play. The NHS tirzepatide patient guide encourages patients to share their full health picture with their prescribing team, not as a gatekeeping exercise, but because it allows for better-calibrated care.

Specific things worth raising at your next review: current smoking status, any plans to quit, any nicotine replacement or cessation medicine you are already using, and whether your appetite has changed in ways you suspect might be related to nicotine rather than tirzepatide. A prescriber who knows all of this can set more meaningful weight-loss targets, interpret progress data more accurately, and support a quit attempt without it derailing your treatment.

If you are thinking about whether Mounjaro is right for your situation more broadly, our Mounjaro guide covers the full licensed picture. Some patients also ask whether Mounjaro has any link to cancer, and we address that question directly on its own page. If cost is part of the decision, our Mounjaro cost page sets out what private treatment involves without any surprises. And if you are ready to talk to a prescriber about your full health picture (smoking included) you can start your free consultation through our weight-loss treatments page; a GPhC-registered prescriber reads every assessment the same day.